Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 25.68B | 25.97B | 29.06B | 37.88B | 27.71B | 20.91B |
Gross Profit | 7.31B | 7.53B | 8.47B | 15.42B | 9.41B | 5.24B |
EBITDA | 4.74B | 4.21B | 4.88B | 12.07B | 6.58B | 2.89B |
Net Income | 527.00M | 674.00M | 1.26B | 7.66B | 3.15B | 459.00M |
Balance Sheet | ||||||
Total Assets | 53.07B | 51.84B | 52.75B | 54.59B | 49.95B | 47.19B |
Cash, Cash Equivalents and Short-Term Investments | 895.00M | 853.00M | 941.00M | 901.00M | 499.00M | 1.45B |
Total Debt | 14.71B | 12.81B | 12.57B | 11.93B | 10.85B | 11.36B |
Total Liabilities | 29.00B | 27.40B | 27.55B | 28.72B | 26.25B | 24.83B |
Stockholders Equity | 24.04B | 24.41B | 25.16B | 25.82B | 23.65B | 22.36B |
Cash Flow | ||||||
Free Cash Flow | 859.00M | 1.38B | 2.47B | 5.67B | 2.10B | 1.77B |
Operating Cash Flow | 2.94B | 3.54B | 5.07B | 8.11B | 3.89B | 3.32B |
Investing Cash Flow | -1.88B | -2.13B | -2.96B | -2.90B | -1.81B | -1.20B |
Financing Cash Flow | -636.00M | -1.45B | -2.06B | -4.73B | -3.00B | -1.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $511.96M | 3.65 | 30.22% | ― | 8.78% | ― | |
71 Outperform | $39.24B | 55.58 | 2.15% | 3.84% | -6.74% | -36.22% | |
58 Neutral | HK$16.25B | 4.26 | -6.43% | 7.78% | -3.39% | -61.30% | |
57 Neutral | $41.57M | ― | -201.16% | ― | -91.55% | -495.60% | |
45 Neutral | C$26.86M | ― | -32.62% | ― | -39.06% | -9.07% | |
43 Neutral | C$8.79M | ― | -35.90% | ― | ― | -16.48% | |
40 Underperform | $11.35M | ― | -32.32% | ― | -47.01% | 95.62% |
Nutrien Ltd. announced the results of its 2025 annual meeting, where 74.48% of common shares were represented. All 12 director nominees were elected with high approval rates, KPMG LLP was re-appointed as auditor, and a non-binding advisory vote on executive compensation was approved. These outcomes reflect strong shareholder support and reinforce Nutrien’s strategic direction and governance.
Nutrien Ltd. has declared a quarterly dividend of US$0.545 per share, payable on July 18, 2025, to shareholders of record as of June 30, 2025. This announcement reflects Nutrien’s commitment to returning value to shareholders and highlights its robust financial position, which supports its strategic investments and operations in the agricultural sector.
Nutrien Ltd. reported its first quarter 2025 results, highlighting net earnings of $19 million and adjusted EBITDA of $0.9 billion. Despite challenges such as weather-related sales delays and increased natural gas costs, the company maintained its full-year guidance, reflecting confidence in its operational efficiency and strategic capital allocation. Nutrien’s strong potash sales and increased ammonia operating rates are expected to support a positive outlook for the year, with plans to focus on high-value investments and shareholder returns.